Zentalis Pharmaceuticals Inc.

ZNTL | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.03

-$0.08 (-2.57%)

At close: Sep 21, 2026, 4:00 PM ET

$3.05

+$0.02 (+0.66%)

Pre-market: Sep 22, 2026, 8:14 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-137.06M	-165.87M	-292.19M	-237.11M	-166.09M	-118.55M
Depreciation & Amortization	739K	1.29M	1.39M	1.43M	544K	160K
Stock-Based Compensation	20.72M	67.27M	54.82M	46.84M	35.74M	23.15M
Other Working Capital	3.19M	6.48M	-5.06M	-2.28M	2.23M	-667K
Other Non-Cash Items	-526K	-57.01M	23.15M	12.61M	-38.38M	556K
Deferred Income Tax	n/a	n/a	-853K	-769K	-2.51M	17K
Change in Working Capital	-9.12M	-16.54M	5.86M	13.25M	16.61M	7.84M
Operating Cash Flow	-125.25M	-170.86M	-207.82M	-163.75M	-154.09M	-86.83M
Capital Expenditures	n/a	-221K	-583K	-2.55M	-6.11M	-758K
Cash Acquisitions	n/a	65K	n/a	111.63K	-14.32M	18.42M
Purchase of Investments	-139.49M	-127.96M	-549.18M	-533.16M	-363.51M	-400.98M
Sales Maturities Of Investments	270.41M	304.68M	505.31M	421.53M	365.82M	116.91M
Other Investing Acitivies	698K	n/a	n/a	-111.63K	n/a	-18.42M
Investing Cash Flow	131.62M	176.56M	-44.46M	-114.18M	-18.12M	-284.83M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-241K	n/a	n/a	-1.15M	18.42M
Financial Cash Flow	-4.28M	108K	237.3M	261.04M	178.52M	360.44M
Net Cash Flow	2.09M	5.81M	-14.98M	-16.89M	6.31M	-11.22M
Free Cash Flow	-125.25M	-171.08M	-208.41M	-166.3M	-160.2M	-87.58M
Adj. Free Cash Flow	-145.97M	-238.35M	-263.23M	-213.14M	-195.94M	-110.73M
Maintenance CapEx	n/a	n/a	-583K	-2.55M	-6.11M	-758K
Growth CapEx	n/a	-221K	n/a	n/a	n/a	n/a
Owner Earnings	-125.25M	-170.86M	-208.41M	-166.3M	-160.2M	-87.58M